Evidence map›Paper›PMID 38716362›Full record

ArticleAnemia2024

Anemia among Medical Students from Jakarta: Indonesia-Iron Deficiency or Carrier Thalassemia?

Raditya Wratsangka, Endrico Xavierees Tungka, Aditya Krishna Murthi, Soegianto Ali, Ita Margaretha Nainggolan, Edhyana Sahiratmadja

Abstract read
In one paragraph

Article in Anemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raditya WratsangkaDepartment of Obstetrics and Gynecology, Faculty of Medicine, Universitas Trisakti, West Jakarta, Indonesia.ORCID https://orcid.org/0000-0001-6254-8336
Endrico Xavierees TungkaDepartment of Biochemistry, Faculty of Medicine, Universitas Trisakti, West Jakarta, Indonesia.ORCID https://orcid.org/0000-0002-7835-3979
Aditya Krishna MurthiDepartment of Medical Physiology, Faculty of Medicine, Universitas Trisakti, West Jakarta, Indonesia.ORCID https://orcid.org/0000-0002-8996-111X
Soegianto AliDepartment of Medical Biology, Biomedical Science Study Program, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, South Jakarta, Indonesia.ORCID https://orcid.org/0000-0002-9972-8696
Ita Margaretha NainggolanBiomedical Science Study Program, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, South Jakarta, Indonesia.ORCID https://orcid.org/0000-0002-9148-4359
Edhyana SahiratmadjaDepartment of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID https://orcid.org/0000-0001-9092-5848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anemia, a global health concern, affects one-fourth of the global population, particularly women. In Indonesia, its prevalence is 23.7%, with 32.0% among 15-24 year-olds. Factors include poor nutrition, infectious diseases, chronic diseases, inherited disorders, and inadequate healthcare access. This study aimed to investigate anemia prevalence and its etiology among medical students from Jakarta. Methods: This study was a descriptive research with a cross-sectional approach. Undergraduate students aged 18-23 years old were selected and consented to participate by a consecutive nonrandom sampling methods. Laboratory blood data were evaluated (including Hb, MCV, MCH, HbA Results: In total, 140 medical students, mainly female, were recruited. Anemia was found in 13.6% (11.4% had low MCV and/or MCH), and 16.5% had low MCV and/or MCH without anemia. Hb electrophoresis revealed high HbA Conclusion: DNA analysis can identify specific mutations associated with alpha-thalassemia, distinguishing between iron deficiency anemia and the alpha-thalassemia trait. Thalassemia screening should involve low MCV and/or MCH values as the first step (stage 1), followed by Hb analysis (stage 2) and DNA analysis (stage 3). In common areas, a combination of Hb and DNA testing is best. However, healthcare professionals must diagnose and treat thalassemia, as proper management relies on accurately identifying the underlying condition.

Identifiers

PMID38716362
PMCPMC11074909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.